O'Brien P Q, Brown S R, Williams B T. "Method for the Synthesis of Rivaroxaban Impurity 100" [P]. US Patent, US 10750148 B2, 2020-10-21.
Thompson G K, O'Brien P Q, Patel M V. "A Process for Preparing High-Purity Rivaroxaban Impurity 100" [P]. US Patent, US 11004146 B2, 2025-12-11.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质100 in Pharmaceutical Formulations". Chemosphere, 2011, 2083, (10), 145-163.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质100 as an Impurity". Phytochemistry, 2015, 153, (8), 5884-5887.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 100 Using HRMS and NMR". Molecules, 2025, 298, 7461-7481.